EIB, iBionext et al. invest $28m in Prophesee

The company's existing investors, iBionext, 360 Capital Partners, Robert Bosch Venture Capital and Supernova Invest, also took part in the round.

Proceeds will be used to accelerate the industrialisation of Prophesee's technology.

Previous funding
This round brings Prophesee's total funding to $68m, according to a press release.

The company was co-founded and seeded by chairperson Bernard Gilly and the iBionext team in 2014. The seed round amounted to an estimated $850,000.

The series-B's first round took place in H2 2016 and saw a consortium of GPs invest $15m in the startup, known as Chronocam at the time. The round, led by Intel Capital, saw Robert Bosch Venture Capital, iBionext, CEA Investissement and Renault-Nissan Group back the business. Altogether, the pool of investors held 15% of Chronocam's share capital.

Finally, iBionext injected further capital in the computer vision technology developer, completing the series-B round started in 2016. 

Company
Prophesee, formely known as Chronocam, develops a neuromorphic vision system. Prophesee's patented neuromorphic sensors and algorithms are used by businesses operating in the autonomous vehicles, industrial automation and security and surveillance sectors, among others. 

Launched in 2014 and based in Paris, the business has offices in Grenoble, China, Japan and the US. It employs 102 engineers and holds around 50 international patents.

People
Prophesee – Luca Verre (co-founder, CEO).
iBionext – Bernard Gilly (chairman).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• France
• Technology
• France